Updated version of this database is available at ThpDB2

Browse result page of THPdb

The total number entries retrieved from this search are 178
ID1005ThPPIDTh1002NameCetuximabPeptide SequenceHeavy chain:QVQLKQSG Full viewLength243Functional ClassificationIIIcDiseaseCancerBrandErbituxCompanyImClone Systems IncPhysical AppearanceSterile, clear, colorless liquid of pH 7.0-7.4, which may contain a small amount of easily visible, white, amorphous cetuximab particulatesRoute of AdministartionIntravenous infusionCategoryAntineoplastic Agents TargetEpidermal growth factor receptor,Low affinity immunoglobulin gamma Fc region receptor III-B,Complement C1r subcomponent,Complement C1q subcomponent subunit A,Complement C1q subcomponent subunit B,Complement C1q subcomponent subunit C,Low affinity immunoglobulin gamma Fc region receptor III-A,Complement C1s subcomponent,High affinity immunoglobulin gamma Fc receptor I,Low affinity immunoglobulin gamma Fc region receptor II-a,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c
ID1025ThPPIDTh1004NameDenileukin diftitoxPeptide SequenceMGADDVVDSSKSFVMENFSS Full viewLength255Functional ClassificationIIbDiseaseCancerBrandOntakCompanySeragen IncPhysical AppearanceSterile, white, preservative-free, lyophilized powder.Route of AdministartionIntravenous(IV) administrationCategoryAntineoplastic Agents TargetInterleukin-2 receptor subunit alpha,Interleukin-2 receptor subunit beta,Cytokine receptor common subunit gamma
ID1028ThPPIDTh1005NameEtanerceptPeptide SequenceLPAQVAFTPYAPEPGSTCRL Full viewLength255Functional ClassificationIIaDiseaseImmunologicalBrandEnbrelCompanyImmunex CorpPhysical AppearanceLyophilized powder.Route of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1029ThPPIDTh1005NameEtanerceptPeptide SequenceLPAQVAFTPYAPEPGSTCRL Full viewLength255Functional ClassificationIIaDiseaseImmunologicalBrandEnbrel SureclickCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents TargetTumor necrosis factor,Tumor necrosis factor receptor superfamily member 1B,Low affinity immunoglobulin gamma Fc region receptor II-b,Low affinity immunoglobulin gamma Fc region receptor II-c,Lymphotoxin-alpha,Low affinity immunoglobulin gamma Fc region re
ID1038ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandEligardCompanyAtrix Labs/QLT InPhysical AppearanceSuspensionRoute of AdministartionSubcutaneous InjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1039ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandEnantoneCompanyTakedaPhysical AppearanceSolutionRoute of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1040ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLeuplinCompanyTakedaPhysical AppearanceN.A.Route of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1041ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLeuProMaxxCompanyBaxter/TevaPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1042ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLeupromerCompanyN.A.Physical AppearanceN.A.Route of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1043ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLupronCompanyAbbott/TAP PharmaceuticalsPhysical AppearanceN.A.Route of AdministartionInjectionCategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1044ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandLutrateCompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1045ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandMemryteCompanyCuraxisPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1046ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandProstap 3CompanyTakeda UK LimitedPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1047ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandProstap SRCompanyTakeda UK LimitedPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1048ThPPIDTh1007NameLeuprolidePeptide SequencePHWSYLLR
Full view
Length8Functional ClassificationIIaDiseaseCancerBrandViadurCompanyBayer AGPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAntineoplastic Agents, Hormonal and fertility agents, estrogen antagonists TargetGonadotropin-releasing hormone receptor
ID1049ThPPIDTh1008NamePeginterferon alfa-2aPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandPegasysCompanyHoffman-La Roche IncPhysical AppearanceSterile, preservative-free, colorless to light yellow injectable solutionRoute of AdministartionSubcutaneous InjectionCategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1055ThPPIDTh1009NameAlteplasePeptide SequenceSYQVICRDEKTQMIYQQHQS Full viewLength255Functional ClassificationIbDiseaseHematological,MetabolicBrandActivaseCompanyGenentech IncPhysical AppearanceSterile, white to off-white, lyophilized powderRoute of AdministartionIntravenousCategoryThrombolytic Agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1
ID1059ThPPIDTh1010NameInterferon alfa-n1Peptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseInfectious /ImmunologicalBrandWellferonCompanyGlaxoSmithKlinePhysical AppearanceSolutionRoute of AdministartionInjectionCategoryAntiviral Agents, Immunologic factors, Immunosuppressiv agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1064ThPPIDTh1011NameDarbepoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandAranespCompanyAmgen IncPhysical AppearanceSterile, colorless, preservative-free solution containing polysorbateRoute of AdministartionIntravenousor Subcutaneous administrationCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1067ThPPIDTh1012NameReteplasePeptide SequenceSYQGNSDCYFGNGSAYRGTH Full viewLength255Functional ClassificationIbDiseaseHematological,MetabolicBrandRetavaseCompanyCentocorPhysical AppearanceSterile, white, lyophilized powderRoute of AdministartionIntravenous InjectionCategoryFibrinolytic Agents, Thrombolytic agents TargetPlasminogen,Fibrinogen alpha chain,Urokinase plasminogen activator surface receptor,Plasminogen activator inhibitor 1
ID1071ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandBinocritCompanySandozPhysical AppearanceClear colourless solutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1072ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandEpoceptCompanyLupin pharmaPhysical AppearanceN.A.Route of AdministartionInjectionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1073ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandEpofitCompanyIntas pharmaPhysical AppearanceN.A.Route of AdministartionN.A.CategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1074ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandEpogenCompanyAmgen Inc.Physical AppearanceSterile, colorless liquidRoute of AdministartionSubcutaneous InjectionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1075ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandEpoginCompanyChugaiPhysical AppearanceN.A.Route of AdministartionSubcutaneous or by Intravenous.CategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1076ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandEprexCompanyJanssen-Cilag. Ortho Biologics LLCPhysical AppearanceSolutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1077ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandNanokineCompanyNanogen Pharmaceutical biotechnology, Vietnam)Physical AppearanceSterile, white, lyophilized powder. The reconstituted preparation with 1 ml solvent (containing 0.9% benzyl alcohol) results in a clear, colorless solution.Route of AdministartionInjectionCategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1078ThPPIDTh1013NameEpoetin alfaPeptide SequenceAPPRLICDSRVLERYLLEAK Full viewLength166Functional ClassificationIbDiseaseHematologicalBrandProcritCompanyOrtho BiotechPhysical AppearanceSterile, colorless liquid in an isotonic sodium chloride/sodium citrate buffered solution or a sodium chloride/sodium phosphate buffered solutionRoute of AdministartionIntravenous(IV) or Subcutaneous (SC) administration.CategoryAnti-anemic Agents, Hematinics TargetErythropoietin receptor
ID1098ThPPIDTh1014NameSalmon CalcitoninPeptide SequenceCSNLSTCVLGKLSQELHKLQ Full viewLength32Functional ClassificationIbDiseaseOsteologicalBrandCalcimarCompanyN.A.Physical AppearanceSolutionRoute of AdministartionSubcutaneous or Intramuscular InjectionCategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents TargetCalcitonin receptor
ID1099ThPPIDTh1014NameSalmon CalcitoninPeptide SequenceCSNLSTCVLGKLSQELHKLQ Full viewLength32Functional ClassificationIbDiseaseOsteologicalBrandForticalCompanyN.A.Physical AppearanceNasal sprayRoute of AdministartionIntranasal useCategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents TargetCalcitonin receptor
ID1100ThPPIDTh1014NameSalmon CalcitoninPeptide SequenceCSNLSTCVLGKLSQELHKLQ Full viewLength32Functional ClassificationIbDiseaseOsteologicalBrandMiacalcinCompanyNovartisPhysical AppearanceSolutionRoute of AdministartionSubcutaneous or Intramuscular InjectionCategoryBone Density Conservation Agents, Antihypercalcemic agents, Anti-osteoporotic agents TargetCalcitonin receptor
ID1110ThPPIDTh1015NameInterferon alfa-n3Peptide SequenceAlpha-2A:CDLPQTHSLG< Full viewLength235Functional ClassificationIbDiseaseImmunologicalBrandAlferonCompanyInterferon Sciences Inc.Physical AppearanceSolutionRoute of AdministartionInjectionCategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1111ThPPIDTh1015NameInterferon alfa-n3Peptide SequenceAlpha-2A:CDLPQTHSLG< Full viewLength235Functional ClassificationIbDiseaseImmunologicalBrandAlferon LDOCompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1112ThPPIDTh1015NameInterferon alfa-n3Peptide SequenceAlpha-2A:CDLPQTHSLG< Full viewLength235Functional ClassificationIbDiseaseImmunologicalBrandAlferon N InjectionCompanyN.A.Physical AppearanceN.A.Route of AdministartionN.A.CategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1117ThPPIDTh1016NamePegfilgrastimPeptide SequenceMTPLGPASSLPQSFLLKCLE Full viewLength175Functional ClassificationIbDiseaseImmunologicalBrandNeulastaCompanyAmgen Inc.Physical AppearanceSolutionRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents, Anti-neutropenic agents TargetGranulocyte colony-stimulating factor receptor,Neutrophil elastase
ID1120ThPPIDTh1017NameSargramostimPeptide SequenceAPARSPSPSTQPWEHVNAIQ Full viewLength127Functional ClassificationIbDiseaseImmunologicalBrandLeucomaxCompanyNovartisPhysical AppearanceSolutionRoute of AdministartionSubcutaneous and Intravenous infusionCategoryImmunosuppressive Agents TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1121ThPPIDTh1017NameSargramostimPeptide SequenceAPARSPSPSTQPWEHVNAIQ Full viewLength127Functional ClassificationIbDiseaseImmunologicalBrandLeukineCompanyBerlex Laboratories IncPhysical AppearanceSterile, preserved (1.1% benzyl alcohol), injectable solution (500 mcg/mL) and also as sterile, white, preservative free lyophilized powder (250 mcg) that requires reconstitution with 1 mL sterile water for InjectionRoute of AdministartionSubcutaneous Injection (SC) or Intravenous infusion (IV)CategoryImmunosuppressive Agents TargetGranulocyte-macrophage colony-stimulating factor receptor subunit alpha,Interleukin-3 receptor subunit alpha,Cytokine receptor common subunit beta,Syndecan-2,Bone marrow proteoglycan
ID1129ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecreFloCompanyRepligen CorpPhysical AppearanceLyophilized white powderRoute of AdministartionIntravenous infusionCategoryDiagnostic Agents TargetSecretin receptor
ID1130ThPPIDTh1018NameSecretinPeptide SequenceHSDGTFTSELSRLRDSARLQ Full viewLength27Functional ClassificationIVDiseaseHormonal disordersBrandSecremaxCompanyRepligen CorpPhysical AppearanceSolutionRoute of AdministartionIntravenousCategoryDiagnostic Agents TargetSecretin receptor
ID1135ThPPIDTh1019NamePeginterferon alfa-2bPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandPEG-IntronCompanySchering CorpPhysical AppearancePowderRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1136ThPPIDTh1019NamePeginterferon alfa-2bPeptide SequenceCDLPQTHSLGSRRTLMLLAQ Full viewLength165Functional ClassificationIbDiseaseImmunologicalBrandUnitron PEGCompanyN.A.Physical AppearanceLyophilized powderRoute of AdministartionSubcutaneous injectionCategoryImmunosuppressive Agents TargetInterferon alpha/beta receptor 1,Interferon alpha/beta receptor 2
ID1145ThPPIDTh1021NameThyrotropin AlfaPeptide SequenceAlpha chain:APDVQDC< Full viewLength204Functional ClassificationIVDiseaseCancerBrandThyrogenCompanyGenzyme IncPhysical AppearanceLyophilized powderRoute of AdministartionIntramuscular preferably the buttocksCategoryDiagnostic Agents TargetThyrotropin receptor
ID1148ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandAdvateCompanyN.A.Physical AppearancePowder formRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1149ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandAlphanateCompanyN.A.Physical AppearanceLyophilized powderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1150ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandBioclateCompanyBaxter Healthcare Corporation, Hyland Division and Genetics Institute, Inc.Physical AppearanceSterile, nonpyrogenic, off-white to faint yellow, lyophilized powderRoute of AdministartionIntravenous infusionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1151ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandHelixate FSCompanyN.A.Physical AppearanceSterile, stable, purified, nonpyrogenic, dried concentrateRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1152ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandHemofil MCompanyN.A.Physical AppearanceDry concentrateRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1153ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandHyate:CCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1154ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandKoate-HPCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2
ID1155ThPPIDTh1022NameAntihemophilic FactorPeptide SequenceATRRYYLGAVELSWDYMQSD Full viewLength255Functional ClassificationIaDiseaseHematological,MetabolicBrandKogenate FSCompanyN.A.Physical AppearancePowderRoute of AdministartionIntravenous InjectionCategoryCoagulants and Thrombotic agents TargetCoagulation factor X,Coagulation factor IX,von Willebrand factor,Phytanoyl-CoA dioxygenase, peroxisomal,Asialoglycoprotein receptor 2,78 kDa glucose-regulated protein,Calreticulin,Calnexin,Protein ERGIC-53,Prolow-density lipoprotein receptor-related protein 1,Multiple coagulation factor deficiency protein 2